» Articles » PMID: 38966281

The Whole Transcriptome Analysis Using FFPE and Fresh Tissue Samples Identifies the Molecular Fingerprint of Osteosarcoma

Overview
Specialty Biology
Date 2024 Jul 5
PMID 38966281
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma is a form of bone cancer that predominantly impacts osteoblasts, the cells responsible for creating fresh bone tissue. Typical indications include bone pain, inflammation, sensitivity, mobility constraints, and fractures. Utilising imaging techniques such as X-rays, MRI scans, and CT scans can provide insights into the size and location of the tumour. Additionally, a biopsy is employed to confirm the diagnosis. Analysing genes with distinct expression patterns unique to osteosarcoma can be valuable for early detection and the development of effective treatment approaches. In this research, we comprehensively examined the entire transcriptome and pinpointed genes with altered expression profiles specific to osteosarcoma. The study mainly aimed to identify the molecular fingerprint of osteosarcoma. In this study, we processed 90 FFPE samples from PathWest with an almost equal number of osteosarcoma and healthy tissues. RNA was extracted from Paraffin-embedded tissue; RNA was sequenced, the sequencing data was analysed, and gene expression was compared to the healthy samples of the same patients. Differentially expressed genes in osteosarcoma-derived samples were identified, and the functions of those genes were explored. This result was combined with our previous studies based on FFPE and fresh samples to perform a meta-analysis. We identified 1,500 identical differentially expressed genes in PathWest osteosarcoma samples compared to normal tissue samples of the same patients. Meta-analysis with combined fresh tissue samples identified 530 differentially expressed genes. , and were some of the most overexpressed genes in osteosarcoma samples, while genes were some of the top downregulated genes. Through the meta-analysis, 530 differentially expressed genes were identified to be identical among FFPE (105 FFPE samples) and 36 fresh bone samples. Deconvolution analysis with single-cell RNAseq data confirmed the presence of specific cell clusters in FFPE samples. We propose these 530 DEGs as a molecular fingerprint of osteosarcoma.

Citing Articles

Imaging, clinical, and histopathological challenges in diagnosing retroperitoneal extraskeletal osteosarcoma.

Ichikawa J, Kawasaki T, Onohara K, Wako M, Taniguchi N, Ochiai S Front Oncol. 2025; 15:1454055.

PMID: 40078181 PMC: 11896851. DOI: 10.3389/fonc.2025.1454055.


Role of arachidonic acid metabolism in osteosarcoma prognosis by integrating WGCNA and bioinformatics analysis.

Wang Y, Hsu P, Hu H, Lin F, Wei X BMC Cancer. 2025; 25(1):445.

PMID: 40075313 PMC: 11905593. DOI: 10.1186/s12885-024-13278-3.


Genetics and Molecular Pathogenesis of the Chondrosarcoma: A Review of the Literature.

Iacobescu G, Corlatescu A, Serban B, Spiridonica R, Costin H, Cirstoiu C Curr Issues Mol Biol. 2024; 46(11):12658-12671.

PMID: 39590345 PMC: 11593320. DOI: 10.3390/cimb46110751.

References
1.
Isakoff M, Bielack S, Meltzer P, Gorlick R . Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015; 33(27):3029-35. PMC: 4979196. DOI: 10.1200/JCO.2014.59.4895. View

2.
Jafari F, Javdansirat S, Sanaie S, Naseri A, Shamekh A, Rostamzadeh D . Osteosarcoma: A comprehensive review of management and treatment strategies. Ann Diagn Pathol. 2020; 49:151654. DOI: 10.1016/j.anndiagpath.2020.151654. View

3.
Jiang Z, Zhou X, Li R, Michal J, Zhang S, Dodson M . Whole transcriptome analysis with sequencing: methods, challenges and potential solutions. Cell Mol Life Sci. 2015; 72(18):3425-39. PMC: 6233721. DOI: 10.1007/s00018-015-1934-y. View

4.
Liu Y, Feng W, Dai Y, Bao M, Yuan Z, He M . Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma. Front Oncol. 2021; 11:709210. PMC: 8335545. DOI: 10.3389/fonc.2021.709210. View

5.
Rathore R, Van Tine B . Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies. J Clin Med. 2021; 10(6). PMC: 8000603. DOI: 10.3390/jcm10061182. View